SciELO - Scientific Electronic Library Online

 
vol.58 issue6Postoperative continuous plexular analgesia: a study on the side effects and risk factors of catheter infectionTako-Tsubo syndrome secondary to residual neuromuscular blockade: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Anestesiologia

Print version ISSN 0034-7094

Abstract

SCHNAIDER, Taylor Brandão; VIEIRA, Antônio Mauro  and  BRANDAO, Antônio Carlos Aguiar. Comparative study of anti-emetics and their association, in the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgeries. Rev. Bras. Anestesiol. [online]. 2008, vol.58, n.6, pp. 614-622. ISSN 0034-7094.  http://dx.doi.org/10.1590/S0034-70942008000600006.

BACKGROUND AND OBJECTIVES: Prophylaxis of postoperative nausea and vomiting has been the subject of several studies. The objective of the present study was to compare anti-emetics, and their association, in the prevention of postoperative nausea and vomiting. METHODS: Seventy patients, ASA I and II, underwent epidural block associated with general anesthesia for gynecologic surgeries. Patients in the Metochlopramide Group (MG) received 20 mg of the drug; the Dexamethasone Group (DeG) received 8 mg; the Droperidol Group (DrG) received 1.25 mg; the Ondansetron Group (OG) received 8 mg; the Dexamethasone-Ondansetron Group (DeOG) received 8 mg and 4 mg, respectively; the Droperidol-Ondansetron Group (DrOG) received 1.25 mg and 4 mg, respectively; the Dexamethasone-Droperidol-Ondansetron Group (DeDrOG) received 8 mg, 0.625 mg, and 4 mg. The presence of nausea and vomiting was evaluated at 6, 12, 24, and 36 hours after the end of the surgery. RESULTS: The total incidence of episodes of nausea per group is as follows: 4 in DeDrOG, 6 in OG, 6 in DrOG, 11 in DeG, 11 in DeOG, 18 in MG, and 22 in DrG. The Chi-square and Fisher exact tests indicated statistically significant differences between DrG and DeG, DOG, DrOG, DeOG, and DeDrOG; between MG and OG, DrOG, and DeDrOG; and between DeOG and DeDrOG. And the incidence of vomiting was: 3 in OG, 3 in DeDrOG, 6 in DrOG, 7 in DeG, 7 in DeOG, and 10 in DrG, and 13 in G. There was a statistically significant difference between DrG and OG and DeDrOG; and between MG and OG and DeDrOG. CONCLUSIONS: The association dexamethasone-droperidol-ondansetron and ondansetron alone were more effective in the prophylaxis of nausea and vomiting.

Keywords : ANTI-EMETICS [dexamethasone]; ANTI-EMETICS [droperidol]; ANTI-EMETICS [metochlopramide]; ANTI-EMETICS [ondansetron]; COMPLICATIONS [nausea]; COMPLICATIONS [vomiting]; SURGERY [gynecologic].

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · pdf in English | Portuguese